WHO has approved the Sinovac-CoronaVac Covid vaccine for emergency use, assuring countries, financiers, procurement agencies and communities that the Chinese pharmaceutical Sinovac’s product “meets international standards for safety, efficacy and manufacturing.” “The world is in desperate need of more vaccines against Covid-19 to tackle the enormous inequality of access on the planet – comments Mariângela Simão, WHO manager for access to health products – We urge manufacturers to participate in the Covax program, share the their know-how and their data and help keep the pandemic under control “.
1 thought on “Covid, ok WHO for emergency use of the Chinese vaccine”
Comments are closed.
https://created.crayola.com/network/members/profile?UserKey=1bb702c8-0426-4236-97a9-b5f5b687d529
https://created.crayola.com/network/members/profile?UserKey=4c5e99d6-2585-47ff-8425-e5ebb7d9caa5
https://created.crayola.com/network/members/profile?UserKey=6642df9b-8012-47b2-8dfb-4e2fceab652d
https://created.crayola.com/network/members/profile?UserKey=54e552f1-0e46-4502-bef5-42fb3d535e70
https://created.crayola.com/network/members/profile?UserKey=fe32f736-7aef-456b-a19e-d5c4740077fd
https://created.crayola.com/network/members/profile?UserKey=19bd3fef-f08b-4527-b917-4f74fc0b1b13
https://created.crayola.com/network/members/profile?UserKey=a4b66b30-e17f-482a-8994-405e39c0acb1
https://created.crayola.com/network/members/profile?UserKey=3b42d863-1a76-4258-a91f-e404419eb033
https://created.crayola.com/network/members/profile?UserKey=24d7ae87-3a33-4fe1-ad8a-4d4a1b5a70ac
https://connect.informs.org/network/members/profile?UserKey=2d5f91b3-5592-4c71-844d-0892a7993ebb
https://connect.informs.org/network/members/profile?UserKey=47865a51-9cc1-438a-816d-4404a7c703e1
https://connect.informs.org/network/members/profile?UserKey=7f63c207-65e8-4481-9df3-a13023ab61ba
https://connect.informs.org/network/members/profile?UserKey=0fd439c2-1c4b-49da-964f-cb70c57f03d1
https://connect.informs.org/network/members/profile?UserKey=00b64d75-624a-43c4-850c-02889a3863ec
https://connect.informs.org/network/members/profile?UserKey=0dacf872-faca-4c24-8914-ee00b572e98f
https://connect.informs.org/network/members/profile?UserKey=4657ef3b-aa36-47c0-bf7d-f1c8f81c0dd8
https://connect.informs.org/network/members/profile?UserKey=0de75301-eb46-4447-9775-fd8baa8783e3
https://connect.informs.org/network/members/profile?UserKey=d6de3bc1-5c5d-42d4-bbf9-b9ee68abf152
https://connect.informs.org/network/members/profile?UserKey=88de7a11-681e-44f4-8573-5f11a515b741
https://connect.informs.org/network/members/profile?UserKey=723b2673-a784-4bbc-aa11-42ed073bf68d
https://connect.informs.org/network/members/profile?UserKey=f9be8d8c-529c-4533-a578-cf425530d6ed
https://connect.informs.org/network/members/profile?UserKey=60961d91-48b8-4edb-9e0d-014a7db18e17
https://connect.informs.org/network/members/profile?UserKey=e98f002d-13ae-43d6-a412-a0b0b0117cdb
https://connect.informs.org/network/members/profile?UserKey=81db40a8-5656-4cae-abae-15de7841deba
https://connect.informs.org/network/members/profile?UserKey=1dee85ce-5de7-4722-bd8a-64be8348d36f
https://connect.informs.org/network/members/profile?UserKey=4a687712-1654-4fad-af29-23bc8234ed34
https://connect.informs.org/network/members/profile?UserKey=8b48e7e8-65ae-485f-9366-bfed68067d4e
https://connect.informs.org/network/members/profile?UserKey=10fcdabb-982b-4119-9101-cfe5de088441
https://connect.informs.org/network/members/profile?UserKey=8052e533-a29d-4da0-839b-68f0d60c2064
https://connect.informs.org/network/members/profile?UserKey=0c20614d-a339-40c4-b639-660cf68038fa
https://connect.informs.org/network/members/profile?UserKey=a095f84f-7aa0-420d-8cd0-6e3be0448fc8
https://connect.informs.org/network/members/profile?UserKey=e95de17b-362f-4721-b8ee-1687ee55c5fa
https://connect.informs.org/network/members/profile?UserKey=c7af1fea-981c-490f-b637-978d8d7f5f18
https://connect.informs.org/network/members/profile?UserKey=127c9db2-f3f0-4163-8a69-4ea7c6d2a504
https://connect.informs.org/network/members/profile?UserKey=7bc2b749-fb38-4402-96ef-db9014d25836
https://connect.informs.org/network/members/profile?UserKey=2621870c-c2e3-4a17-bfdc-dcecb962be35
https://connect.informs.org/network/members/profile?UserKey=31850561-e56f-44f4-81de-692f7bae32a2
https://connect.informs.org/network/members/profile?UserKey=4d88a90d-79fc-4fc6-85cf-af7854ba28f2
https://connect.informs.org/network/members/profile?UserKey=219d9b9b-230b-4f5d-b2ee-fc02637c7464
https://connect.informs.org/network/members/profile?UserKey=573f083a-f768-46e5-9512-82249327aa1e
https://connect.informs.org/network/members/profile?UserKey=f9913fa6-833c-4bc4-9cee-71c688deaf57
https://connect.informs.org/network/members/profile?UserKey=b4bd25a2-70d8-4eb7-ad16-bd650a6b2248
https://connect.informs.org/network/members/profile?UserKey=b5d37f44-b26f-4b3f-8864-20800119c933
https://connect.informs.org/network/members/profile?UserKey=453add00-9c04-42a5-af3e-de53c4896cb2
https://connect.informs.org/network/members/profile?UserKey=c3ec3cd5-8448-4092-804d-89c45b847356
https://connect.informs.org/network/members/profile?UserKey=6421c521-f7be-4ed3-8520-61a0bd739ac5
https://connect.informs.org/network/members/profile?UserKey=86435865-2d0b-4239-b9bc-35abe405ecdb
https://connect.informs.org/network/members/profile?UserKey=cf410941-501d-4a9d-a822-c22c325ad4fe
https://connect.informs.org/network/members/profile?UserKey=d90e6425-a129-4fe3-88e6-09a3c1ccd1e6
https://connect.informs.org/network/members/profile?UserKey=529a96cd-3977-4700-b2e2-e47e8bfc2806